Latest Articles & Resources FEATURED How Bayer Focuses Supplier Management on 19 Key Partnerships Read More » How Bayer Focuses Supplier Management on 19 Key Partnerships Read More » LATEST NEWS + INTERVIEWS NorthX Biologics and Mendus Expand Cell Therapy Manufacturing Collaboration Evonik Manufactures First GMP Lipid Batch at New US Facility Curia Completes $5.48 Million Investment in León, Spain Facility Scispot Partners With KCAS Bio to Advance Laboratory Digital Transformation BDR Pharma Expands CDMO Capabilities With Acme Formulation Acquisition ProBio Licenses Discovery-Stage Oncology Antibody Asset to AbTis AGC Biologics Partners With Child’s Cure on mRNA Therapy for CDKL5 Disorder ProBioGen Expands GMP Manufacturing to Viral Vectors and Vaccines Simtra BioPharma Opens $250 Million Manufacturing Expansion in Indiana PharmaLogic to Acquire Lantheus CDMO Business and New Jersey Manufacturing Facility MedPharm Adds First-to-File Generic Topical Product to Manufacturing Portfolio PluriCDMO Secures ISO 9001 and ISO 13485 Certifications for Manufacturing Services Charles River Laboratories to Acquire Frontage Bioanalysis and DMPK Business for $470 Million What Lonza’s Merck KGaA Deal Means for ADC Manufacturing in the United States Charles River to Buy Frontage’s Bioanalysis and DMPK Units for $470M CDMO Live Americas Report 2026 [DOWNLOAD] DC Decoded: How Section 232 Tariffs and FDA Upheaval Are Reshaping US Contract Manufacturing with Gil Roth and Marta Wosińska Crystal Pharmatech Launches Automated MicroED Services in China PharmAla Biotech Selects Corealis Pharma for ALA-002 GMP Manufacturing AGC Biologics Expands Manufacturing Agreement Beyond $580 Million Beyond Testing: How Clinical Laboratory Services Influence Drug Development Outcomes PODCAST INTERVIEWS DC Decoded: How Section 232 Tariffs and FDA Upheaval Are Reshaping US Contract Manufacturing with Gil Roth and Marta Wosińska “You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026
DC Decoded: How Section 232 Tariffs and FDA Upheaval Are Reshaping US Contract Manufacturing with Gil Roth and Marta Wosińska
DC Decoded: How Section 232 Tariffs and FDA Upheaval Are Reshaping US Contract Manufacturing with Gil Roth and Marta Wosińska
“You Can’t Have Your Cake and Eat It”: Pfizer, Biogen, Astellas and ROIS on Network Strategy in an Uncertain Landscape
State of the Industry: Five Takeaways on Tariffs, Reshoring, China and Talent from CDMO Live Americas 2026
